Idiopathic Diseases of Man
Part of paid clinical trials in La Jolla, California.
- Sponsor
- Scripps Translational Science Institute
- Study ID
- NCT01440218
- Status
- Enrolling By Invitation
Conditions
- Idiopathic Disease
- Rare Disease
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
This research is being done to learn more about possible genetic causes of currently undiagnosed conditions, and to find out how the development of new technologies, such as DNA sequencing, can increase knowledge of the role genetic variants play in disorders and possibly how genetic variants may help de-termine the best treatment options. The recent development of new technologies has increased our ability to understand how genetic mutations are associated with disease. Using these technologies to find the genetic variants responsible for rare diseases is a rapidly growing field and has already begun to transform the way conditions with unknown causes are diagnosed and treated. Hypothesis: Identification of new genomic variants associated with idiopathic diseases and/or diseases of unknown etiology will advance medical knowledge about rare and common diseases.
Key Dates
- Start date
- Sep 30, 2011
- Status verified
- Jan 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 10 participants (estimated)
Arms
- Arm: Patients with idiopathic diseasesStudy population is limited to individuals with a rare severe illness, and/or their family members.
Primary Outcome Measure
Genomic sequencing of tissue [ Time Frame: Day 1 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Scripps Translational Science Institute | La Jolla | California | 92037 | - |